Urologic Neoplasms clinical trials at University of California Health
4 in progress, 1 open to eligible people
Bladder Fiducial Markers and Multiparametric-MRI (mp-MRI) to Optimize Bladder Chemo-radiotherapy
open to eligible people ages 18 years and up
The purpose of this study is to examine the usefulness of implanting small 24-K gold fiducial markers around a bladder tumor site, so that a Radiation Oncologist can identify the original tumor location at the time of radiation treatment. Other…
at UCLA
Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
Sorry, in progress, not accepting new patients
This study will test an experimental drug (enfortumab vedotin) alone and with different combinations of anticancer therapies. Pembrolizumab is an immune checkpoint inhibitor (CPI) that is used to treat patients with cancer of the urinary system…
at UC Davis UC Irvine UCSD UCSF
Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Sorry, in progress, not accepting new patients
This trial studies how well tucatinib works for solid tumors that make either more HER2 or a different type of HER2 than usual (HER2 alterations) The solid tumors studied in this trial have either spread to other parts of the body (metastatic) or…
at UCSD
Ph2 Study NKT2152 with Palbociclib & Sasanlimab in Subjects with Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
Sorry, in progress, not accepting new patients
The goal of the Lead-in phase of the study is to evaluate the safety, efficacy, pharmacokinetics (PK) and determine recommended dose for expansion (RDE) of NKT2152 in combination with palbociclib (Doublet) and with palbociclib and sasanlimab…
at UCSD
Last updated: